| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/05/2009 | CN101496846A Medicament composition containing bifendate and Chinese medicine extract |
| 08/05/2009 | CN101496845A Hedyotis diffusa Willd. extract and method for separating and preparing the same |
| 08/05/2009 | CN101496840A Chinese medicine compound granules for rapidly treating toothache |
| 08/05/2009 | CN101496839A Chinese medicine compound and preparation method thereof |
| 08/05/2009 | CN101496822A Composite probiotics micro-ecological formulation and preparation method |
| 08/05/2009 | CN101496819A Eubacterium, Clostridium preparation and use thereof |
| 08/05/2009 | CN101496815A Medicament for treating hepatic failure and preparation method thereof |
| 08/05/2009 | CN101496813A Anti-hyperblastosis (vascular restenosis) composition and application method |
| 08/05/2009 | CN101496809A Application of forsythiaside B in preparing medicament for treating or preventing acute and chronic liver damnification and liver fibrosis |
| 08/05/2009 | CN101496807A Medicament composition with function for protecting liver and reducing enzyme activity |
| 08/05/2009 | CN101496805A Application of 4-acetyl diazene quinoline derivatives in preparing anti-tumor medicament |
| 08/05/2009 | CN101496787A Prostaglandin E1 lipid microsphere injection with charge effect and preparation method thereof |
| 08/05/2009 | CN101496636A Method for preparing and using functional plant stuffing for thin sheet raw material of paper-making process |
| 08/05/2009 | CN101496583A Nutrient foodstuffs containing probiotic and preparation method thereof |
| 08/05/2009 | CN101496578A Special diet and foodstuffs formula containing small peptide for hepatopath |
| 08/05/2009 | CN100522992C Novel ring-shape small-peptide BA and its use |
| 08/05/2009 | CN100522991C Peptidomimetic protease inhibitors |
| 08/05/2009 | CN100522976C Novel azacyclic ethynyl derivatives |
| 08/05/2009 | CN100522972C Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522946C Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/05/2009 | CN100522944C Carboxylic acid derivative and thereof |
| 08/05/2009 | CN100522943C Vitamin d analogues |
| 08/05/2009 | CN100522234C Medicine for restoring gastric mucosa |
| 08/05/2009 | CN100522217C Tablets made of hedgehog hydnum for stomach-health and its preparation process |
| 08/05/2009 | CN100522207C Novel herbal composition for the treatment of gastric ulcer |
| 08/05/2009 | CN100522196C Medicine or foods for prevention and treatment of microcirculation disorder and disease of live habits |
| 08/05/2009 | CN100522175C Sustained release tablet of oleanolic acid and its preparation method |
| 08/05/2009 | CN100522167C Palonosetron injection and its powder injection preparation of salt receptable on medicine and its preparing method |
| 08/05/2009 | CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists |
| 08/05/2009 | CN100522165C Lansoprazole intestine solution capsule and its preparation method |
| 08/05/2009 | CN100522154C Use of isothiocyanates compound for treatment of helicobacter |
| 08/05/2009 | CN100522138C Preparation process and quality control technology of decoction of bupleurum root for regulating Shaoyang |
| 08/05/2009 | CN100521962C Process for producing lacturose-containing powder composition, lacturose-containing powder composition obtained by the process and feed additive |
| 08/05/2009 | CN100521957C Supine gynura root and producing method thereof |
| 08/04/2009 | US7569697 Benzimidazole compound crystal |
| 08/04/2009 | US7569696 Process for producing crystal |
| 08/04/2009 | US7569598 Isomerization; crystallization |
| 08/04/2009 | US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 08/04/2009 | US7569569 Pyrrolo[2,3-d]pyrimidine compounds |
| 08/04/2009 | US7569387 Specifically binds an MK61 polypeptide produced by immunizing an animal |
| 08/04/2009 | US7569227 Monomeric protein of the TGF-β family |
| 08/04/2009 | US7569225 Immunogenic lipopeptides comprising T-helper and B-cell epitopes |
| 08/04/2009 | CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/04/2009 | CA2424566C Dental care compositions |
| 08/04/2009 | CA2406057C Methods and compositions for modulating alpha adrenergic receptor activity |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/03/2009 | WO2006079903A1 Antacid lozenge containing micronized salts |
| 08/03/2009 | CA2595984A1 Antacid lozenge containing micronized salts |
| 07/30/2009 | WO2009094464A2 Dietary compositions and related methods of use |
| 07/30/2009 | WO2009094191A2 Methods of treating viral infections |
| 07/30/2009 | WO2009094190A2 Methods of treating viral infections |
| 07/30/2009 | WO2009093755A1 Agent for increasing blood adiponectin quantity |
| 07/30/2009 | WO2009093736A1 Tablet comprising kanpo herbal medicine and pantethine component |
| 07/30/2009 | WO2009093735A1 Pharmaceutical composition |
| 07/30/2009 | WO2009093605A1 Anti-canine periodontal disease composition |
| 07/30/2009 | WO2009093353A1 Medicinal composition |
| 07/30/2009 | WO2009093334A1 Antacid |
| 07/30/2009 | WO2009092994A1 Novel salt of tegaserod |
| 07/30/2009 | WO2009092993A1 Novel salt of tegaserod |
| 07/30/2009 | WO2009092442A1 Treatment of portal hypertension and related conditions by combined inhibition of the vegf and pdgf signalling pathways |
| 07/30/2009 | WO2009092284A1 Benzocycloheptene derivatives, preparing processes and pharmaceutical uses thereof |
| 07/30/2009 | WO2009064460A3 Gastrointestinal delivery systems |
| 07/30/2009 | WO2009063248A3 Polymorphic forms of tegaserod glutarate |
| 07/30/2009 | WO2009050242A3 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 07/30/2009 | WO2008149140A3 Tegaserod oxalate and polymorphic forms |
| 07/30/2009 | WO2008149139A3 Tegaserod fumarate and polymorphic forms |
| 07/30/2009 | WO2008052044A3 Use of derivatives of propofol for treating diseases associated with oxidative stress |
| 07/30/2009 | WO2008040155A8 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/30/2009 | US20090192293 Antibodies to non-functional p2x7 receptor |
| 07/30/2009 | US20090192292 Murine zcytor17 ligand polypeptides and polynucleotides |
| 07/30/2009 | US20090192164 Treating agent of inflammatory bowel disease |
| 07/30/2009 | US20090192161 Amorphous and Crystalline Forms of Aprepitant and Processes for the Preparation Thereof |
| 07/30/2009 | US20090192160 Compounds |
| 07/30/2009 | US20090192138 compounds |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192095 Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
| 07/30/2009 | US20090191265 comprises 5-30% by wt of pharmaceutically acceptable excipients and 70-95% of 5-methyl-1-phenyl-2-(1H)-pyridone, where excipients comprise effective amount of binder to increase changes in blood concentration of pirfenidone upon oral administration, compared to capsule comprising no excipients; fibrosis |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | CA2714269A1 Novel salt of tegaserod |
| 07/30/2009 | CA2713105A1 Methods of treating viral infections |
| 07/30/2009 | CA2711576A1 Tricyclic compounds as modulators of tnf-.alpha. synthesis and as pde4 inhibitors |
| 07/29/2009 | EP2082750A1 Oral recombinant helicobacter pylori vaccine and preparing method thereof |
| 07/29/2009 | EP2081939A1 Benzimidazole derivatives as selective acid pump inhibitors |
| 07/29/2009 | EP2081600A1 Combination of nmda- receptor ligand and a compound with 5-ht6 receptor affinity |
| 07/29/2009 | EP2081560A1 Treatment of gastrointestinal diseases |
| 07/29/2009 | EP2081546A2 Multiple unit tablet compositions of benzimidazole compounds |
| 07/29/2009 | EP1558277A4 Treatment of inflammatory bowel disease |
| 07/29/2009 | EP1513527B1 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers |
| 07/29/2009 | EP1397357B1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/29/2009 | EP1293567B1 Ligand to gpr8 and dna thereof |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | CN100519757C Tiacumicin production |
| 07/29/2009 | CN100519554C CCR5 antagonists for treating aids |
| 07/29/2009 | CN100519552C Pyrazole compounds |
| 07/29/2009 | CN100519549C Pyrimidine derivatives and pharmaceutical compositions containing the compounds |
| 07/29/2009 | CN100519539C N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100519526C Azabicyclo derivatives as muscarinic receptor antagonists |
| 07/29/2009 | CN100518749C Medicine for treating oral exulceratio and periodontal turgescene, and preparation method thereof |